FDA Inspection 1098274 — Biomat USA, Inc

Biomat USA, Inc — FEI 1643256

The FDA completed an inspection of Biomat USA, Inc on June 21, 2019 in McAllen, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 21, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Blood and Blood Products
Location
McAllen, TX (United States)